SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-16-676860
Filing Date
2016-08-09
Accepted
2016-08-09 16:45:02
Documents
4
Effectiveness Date
2016-08-09

Document Format Files

Seq Description Document Type Size
1 DEFA14A d219027ddefa14a.htm DEFA14A 18139
2 GRAPHIC g219027g01d88.jpg GRAPHIC 5514
3 GRAPHIC g219027g23e25.jpg GRAPHIC 11967
4 GRAPHIC g219027g87x00.jpg GRAPHIC 5430
  Complete submission text file 0001193125-16-676860.txt   50845
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36296 | Film No.: 161818585
SIC: 2834 Pharmaceutical Preparations